Federal Patient Safety Initiatives Panel Summary
Year: 2002
Type: article
Abstract: The participants in this panel described major federal initiatives aimed at improving patient safety. Summaries of the panelists' remarks follow in the order of presentation at the Symposium. Medication errors have multiple causes including: poor communication, name confusion, abbreviations, poor techniques, knowledge deficit, inexperience, and confirmation bias. In addition to the patient, hospitals, practitioners, manufacturers, and governments can also be victims of medication errors. The FDA has collected more than 20,000 medication errors since 1993 and data reflect a 10% mortality rate. In order to combat medication errors, the FDA has initiatives in the area of pre-marketing, post-marketing, risk management, and research ( Table 1 ). For more information see < http://www.fda.gov/ >. ... The FDA is involved in numerous risk communication activities including publishing in professional journals such as AHSP, JAMA, and NEJM and through the consumer-oriented FDA Today. Other risk minimization activities include improved labeling, letters to physicians, education, restricted access to a particular drug, and withdrawal from the market. In addition, the FDA collaborates with other organizations such as the AMA, AHSP, USP, and Institute for Safe Medication practices.
Authors: L. A. Lenert, H. Burstin, L. Connell, J. Gosbee, G. Phillips
Language: English
Subfield: Emergency Medical Services
Field: Health Professions
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2175577883